Astral Systems

Producing life-saving cancer isotopes through compact fusion technology.

Bristol, United Kingdom · Founded 2021 · $30.0M raised

Headquarters
Bristol
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series AJun 2026
Rounds
1

About

Astral Systems is a Bristol-based deep tech company developing Multi-State Fusion (MSF) reactor technology to produce medical isotopes for cancer diagnosis and treatment. Its compact fusion reactors generate high-intensity neutron beams that irradiate target materials to create radioisotopes including Actinium-225 and Lead-212 — isotopes in critical short supply globally. Astral's reactors operate at Technology Readiness Level 9, with the company having generated over £3M in research contract revenue. Founded in 2021 by Talmon Firestone and Dr. Tom Wallace-Smith, the company builds on NASA's discovery of lattice confinement fusion and a decade of NSD fusion commercialization. It raised a £23M Series A in 2026 to scale production.

Summary

Astral Systems is a Deep Tech company based in Bristol, United Kingdom, founded in 2021. It has raised $30.0M in total across 1 round, most recently a $30.0M Series A round in Jun 2026. Investors include Mercia Fund Management.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors

Similar Companies